bgcolor="#ffffff" align="center" colspan="2" |
Xylometazoline |
align="center" colspan="2" | 2-((4-(1,1-dimethylethyl)-2,6-
dimethylphenyl)methyl)-4,5-dihydro-
1H-imidazole (9CI) |
CAS number
526-36-3 | ATC code
R01AA07, S01GA03 |
| bgcolor="#eeeeee" | Chemical formula | bgcolor="#ddeeff" | CHN |
| bgcolor="#eeeeee" | Molecular weight | bgcolor="#ddeeff" | 244.38 |
| bgcolor="#eeeeee" | Bioavailability | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Metabolism | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Elimination half-life | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Excretion | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Pregnancy category | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Legal status | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Routes of administration | bgcolor="#ddeeff" | ? |